Sareum - Specialists in Structure-based Drug Discovery
Print the page Smaller text Larger text

 

Final Results
27 November, 2008

End of Offer Period
16 September, 2008

Resignation of Director, Update on Strategic Review
29 August, 2008

Disposal of Assets
26 August, 2008

Directorate Change
11 July, 2008

RSS news feed News feed
requires RSS news reader

Sareum Holdings
Last Trading 0.14
Trade Time 14:43am
Change -0.03
Open 0.18
Day's Range 0.138 - 0.15
Volume 700000

Sareum's small molecule drug discovery expertise is building value by developing oncology drug candidates for licencing to pharmaceutical and biotechnology companies

Providing protein structure-based research services to accelerate customers’ drug discovery programmes
Developing oncology drug candidates for licensing to pharmaceutical companies
Learn more about Sareum’s pre-clinical oncology pipeline of targeted small molecule drug candidates

 

Website last updated on: 31-August-2008
 


Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader


site map

email: info@sareum.co.uk tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701